Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Imatinib | HCID 5291 | — |
| Reactant | Methanesulfonic Acid | HCID 6395 | — |
| Reactant | tert-Butyl methyl ether | HCID 15413 | — |
| Solvent | Ethanol | HCID 702 | — |
| Product | Imatinib Mesylate | HCID 123596 | — |
Reaction Steps
Imatinib base (60 g; 0.1216 mole) was suspended in 1200 ml of Ethanol and stirred. Reactor was kept under flow of nitrogen during all of the experiment (6 liters per hour). Then, 24 ml of water was added to the suspension and the temperature was adjusted at −15° C. An ethanolic solution of methanesulfonic acid (79.8 ml 10% V/V; 0.1213 mole) was added during 2 minutes to the reaction mixture. Temperature of the solution was set at −10° C. during 10 minutes, imatinib base was dissolved and seeding material of form X (2 g) was added. The crystallization process was continued under stirring for 190 minutes and temperature was continuously increased to −5° C. The suspension was stored overnight in a freezer at approx. −27° C. Than, suspension was diluted by 1000 ml TBME, filtered by nitrogen pressure and obtained crystalline portion was washed with 400 ml TBME. The resulted crystalline form X was dried by flow of nitrogen through the filter to remove free ethanol. Ethanol content was about 7.5%. (Yield was 67.95 g; 85%)
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07977348B2 |
|---|
| Source dataset | uspto-grants-2011_07 |
|---|
| ORD ID | ord-1a3936cb22fa4105badb6cbd27bb2c8f |
|---|
| Source note | uspto-grants-2011_07 |
|---|